Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials

Published:2023-10-02 Issue:4 Volume:28 Page:297-309
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Thng Zheng Xian¹²^ORCID,Bromeo Albert John¹³^ORCID,Mohammadi S. Saeed¹,Khatri Anadi¹⁴⁵^ORCID,Tran Anh N.T.¹,Akhavanrezayat Amir¹^ORCID,T.T. Than Ngoc¹,Nguyen Khiem S.¹,Yoo Woong-Sun¹⁶^ORCID,Mobasserian Azadeh¹,Or Christopher Chi Mong¹,Nguyen Quan Dong¹

Affiliation:

1. Byers Eye Institute, Stanford University, Palo Alto, California, USA

2. National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore

3. Asian Eye Institute, Makati, Philippines

4. Birat Aankha Aspatal, Biratnagar, Nepal

5. Department of Ophthalmology, Birat Medical College and Teaching Hospital, Kathmandu University, Biratnagar, Nepal

6. Department of Ophthalmology, Gyeongsang National University College of Medicine, and Gyeongsang National University Hospital, Jinju, Republic of Korea

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2023.2293049

Reference104 articles.

1. Uveitis

2. Regular review: Management of chronic uveitis

3. Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop

4. A Focus on the Epidemiology of Uveitis

5. A systematic approach to emergencies in uveitis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP